Insider · CIK 0000901056

SAMSON MARVIN

Reports to the SEC for 2 companies · EWING, NJ

sec.gov

Transactions

Companies

Filings

CIK

0000901056

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-01-10	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+56 sh	$2.66	+$148.96	51,807
2020-01-10	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−56 sh	—	—	0
2020-01-10	ANTARES PHARMA, INC.S Sale	Director	SSale	−56 sh	$4.50	−$252	51,751
2020-01-02	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−99.4K sh	—	—	0
2020-01-02	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$2.18	+$109K	101,751
2020-01-02	ANTARES PHARMA, INC.S Sale	Director	SSale	−50K sh	$4.59	−$230K	51,751
2020-01-02	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+49.4K sh	$2.18	+$108K	101,146
2020-01-02	ANTARES PHARMA, INC.S Sale	Director	SSale	−49.4K sh	$4.60	−$227K	51,751
2020-01-02	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+549 sh	$2.66	+$1,460.34	52,300
2020-01-02	ANTARES PHARMA, INC.S Sale	Director	SSale	−549 sh	$4.60	−$2,525.4	51,751
2020-01-02	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−549 sh	—	—	0
2019-12-23	ANTARES PHARMA, INC.S Sale	Director	SSale	−150K sh	$4.71	−$707K	51,751
2019-12-23	ANTARES PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+150K sh	$1.12	+$168K	201,751
2019-12-23	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−150K sh	—	—	0
2019-11-11	ANTARES PHARMA, INC.G Gift	Director	GGift	−25K sh	$3.77	−$94.3K	51,751
2019-06-13	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+46.7K sh	—	—	46,729
2019-06-13	ANTARES PHARMA, INC.A Award	Director	AAward	+24K sh	$2.92	+$70K	76,751
2018-06-08	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+76.5K sh	—	—	76,548
2017-06-07	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+80.3K sh	—	—	80,318
2017-04-10	ANTARES PHARMA, INC.G Gift	Director	GGift	−50K sh	$2.80	−$140K	52,778
2016-06-02	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2016-03-18	ANTARES PHARMA, INC.P Purchase	Director	PPurchase	+50K sh	$0.72	+$36K	102,778
2015-05-28	ANTARES PHARMA, INC.Stock option (right to buy)A Award	Director	AAward	+99.4K sh	—	—	99,395
2014-08-11	ANTARES PHARMA, INC.P Purchase	Director	PPurchase	+25K sh	$2.00	+$49.9K	52,778
2013-05-22	ANTARES PHARMA, INC.A Award	Director	AAward	+27.8K sh	—	—	27,778
2013-05-22	ANTARES PHARMA, INC.Stock option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2004-01-20	SICOR INCS Sale	Chief Executive Officer	SSale	−250K sh	$27.66	−$6.91M	0
2004-01-20	SICOR INCM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+250K sh	$10.12	+$2.53M	0
2004-01-20	SICOR INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−25K sh	—	—	0
2004-01-20	SICOR INCM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1M sh	$15.75	+$15.8M	0
2004-01-20	SICOR INCS Sale	Chief Executive Officer	SSale	−1M sh	$27.66	−$27.7M	0
2004-01-20	SICOR INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−250K sh	—	—	0
2004-01-20	SICOR INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1M sh	—	—	0
2004-01-20	SICOR INCS Sale	Chief Executive Officer	SSale	−25K sh	$27.66	−$691K	0
2004-01-20	SICOR INCM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+25K sh	$15.19	+$380K	0
2004-01-16	SICOR INCIncentive Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+35K sh	—	—	0

Recent filings

Accepted (ET)
Jan 144
SAMSON MARVIN0001209191-20-003358
SEC(opens sec.gov)
Jan 64
SAMSON MARVIN0001209191-20-002077
SEC(opens sec.gov)
Dec 264
SAMSON MARVIN0001209191-19-061964
SEC(opens sec.gov)
Nov 134
SAMSON MARVIN0001209191-19-056446
SEC(opens sec.gov)
Jun 144
SAMSON MARVIN0001209191-19-037250
SEC(opens sec.gov)
Jun 114
SAMSON MARVIN0001209191-18-037119
SEC(opens sec.gov)
Jun 94
ANTARES PHARMA, INC.0001209191-17-038881
SEC(opens sec.gov)
Apr 124
ANTARES PHARMA, INC.0001209191-17-026721
SEC(opens sec.gov)

Companies

Address

C/O ANTARES PHARMA, INC. 100 PRINCETON SOUTH, SUITE 300

EWING, NJ, 08628